Nanoporous silica microparticle interaction with toll-like receptor agonists in macrophages

Acta Biomaterialia

Volumn 8, Issue 12, 2012, Pages 4295-4303

  Cejudo Guillen M ^a,b   Ramiro Gutierrez M L ^c,d   Labrador Garrido, A ^a,b   Diaz Cuenca A ^c,d   Pozo, D ^a,b,e  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c CSIC   (Spain)

^d BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^e Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

Author keywords

Innate immunity; Macrophage; Nanoporous silica microparticles; Toll like receptor

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CELL MEMBRANES; DRUG DELIVERY; IMMUNE SYSTEM; PHYSIOLOGY; SCAFFOLDS (BIOLOGY); SILICA NANOPARTICLES;

CELL VIABILITY; DRUG-DELIVERY SYSTEMS; INNATE IMMUNITY; MICRO PARTICLES; NANOPOROUS SILICA; NANOPOROUS SILICUM MICROPARTICLE; POTENTIAL DRUG; RAW 264.7 CELLS; TISSUES ENGINEERINGS; TOLL-LIKE RECEPTORS;

MACROPHAGES;

INTERLEUKIN 10; INTERLEUKIN 6; SILICON DIOXIDE; TOLL LIKE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL COMPARTMENTALIZATION; CELL SURFACE; CELL VIABILITY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; MACROPHAGE ACTIVATION; MOUSE; NANOPORE; NONHUMAN; PARTICLE SIZE; PH; POLARIZATION; PRIORITY JOURNAL; TISSUE ENGINEERING; ZETA POTENTIAL;

EID: 84868203896     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.07.026     Document Type: Article

References (60)

1. D.Y. Zhao, J.L. Feng, Q.S. Huo, N. Melosh, G.H. Fredrickson, and B.F. Chmelka Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores Science 279 1998 548 552 (Pubitemid 28067280)
2. B. Fadeel, and A.E. Garcia-Bennett Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications Adv Drug Deliv Rev 62 2010 362 374
3. G. Soler-Illia, E.L. Crepaldi, D. Grosso, and C. Sanchez Block copolymer-templated mesoporous oxides Curr Opin Colloid Interface Sci 8 2003 109 126 (Pubitemid 36755216)
4. A. Sundblom, C.L.P. Oliveira, J.S. Pedersen, and A.E.C. Palmqvist On the formation mechanism of pluronic-templated mesostructured silica J Phys Chem C 114 2010 3483 3492
5. Y. Wan, and D. Zhao On the controllable soft-templating approach to mesoporous silicates Chem Rev 107 2007 2821 2860 (Pubitemid 47177108)
6. I.I. Slowing, J.L. Vivero-Escoto, B.G. Trewyn, and V.S. Lin Mesoporous silica nanoparticles: structural design and applications J Mat Chem 20 2010 7924 7937
7. P. Linton, J.C. Hernandez-Garrido, P.A. Midgley, H. Wennerstrom, and V. Alfredsson Morphology of SBA-15-directed by association processes and surface energies Phys Chem Chem Phys 11 2009 10973 10982
8. Y.F. Hu, K. Qian, P. Yuan, Y.H. Wang, and C.Z. Yu Synthesis of large-pore periodic mesoporous organosilica Mater Lett 65 2011 21 23
9. R.F. Hamilton Jr., S.A. Thakur, and A. Holian Silica binding and toxicity in alveolar macrophages Free Radic Biol Med 44 2008 1246 1258
10. G. Soler-Illia, and O. Azzaroni Multifunctional hybrids by combining ordered mesoporous materials and macromolecular building blocks Chem Soc Rev 40 2011 1107 1150
11. R. Klippstein, and D. Pozo Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies Nanomed Nanotechnol Biol Med 6 2010 523 529
12. M. Zhu, H. Wang, J. Liu, H. He, X. Hua, and Q. He A mesoporous silica nanoparticulate/beta-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy Biomaterials 32 2011 1986 1995
13. A. Suwalski, H. Dabboue, A. Delalande, S.F. Bensamoun, F. Canon, and P. Midoux Accelerated Achilles tendon healing by PDGF gene delivery with mesoporous silica nanoparticles Biomaterials 31 2010 5237 5245
14. X. Huang, X. Teng, D. Chen, F. Tang, and J. He The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function Biomaterials 31 2010 438 448
15. Q. He, J. Zhang, J. Shi, Z. Zhu, L. Zhang, and W. Bu The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses Biomaterials 31 2010 1085 1092
16. P. Yang, Z. Quan, L. Lu, S. Huang, and J. Lin Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems Biomaterials 29 2008 692 702 (Pubitemid 350181037)
17. I.I. Slowing, J.L. Vivero-Escoto, C.W. Wu, and V.S.Y. Lin Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Adv Drug Deliv Rev 60 2008 1278 1288
18. J.L. Vivero-Escoto, I.I. Slowing, B.G. Trewyn, and V.S. Lin Mesoporous silica nanoparticles for intracellular controlled drug delivery Small 6 2010 1952 1967
19. M. Alcaide, P. Portoles, A. Lopez-Noriega, D. Arcos, M. Vallet-Regi, and M.T. Portoles Interaction of an ordered mesoporous bioactive glass with osteoblasts, fibroblasts and lymphocytes, demonstrating its biocompatibility as a potential bone graft material Acta Biomater 6 2010 892 899
20. L.V. Carvalho, C. Ruiz Rde, K. Scaramuzzi, E.B. Marengo, J.R. Matos, and D.V. Tambourgi Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15 Vaccine 28 2010 7829 7836
21. J. Choi, Q. Zheng, H.E. Katz, and T.R. Guilarte Silica-based nanoparticle uptake and cellular response by primary microglia Environ Health Perspect 118 2010 589 595
22. Z. Tao, M.P. Morrow, T. Asefa, K.K. Sharma, C. Duncan, and A. Anan Mesoporous silica nanoparticles inhibit cellular respiration Nano Lett 8 2008 1517 1526
23. S.P. Hudson, R.F. Padera, R. Langer, and D.S. Kohane The biocompatibility of mesoporous silicates Biomaterials 29 2008 4045 4055
24. Z. Tao, B.B. Toms, J. Goodisman, and T. Asefa Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials Chem Res Toxicol 22 2009 1869 1880
25. S. Al-Salam, G. Balhaj, S. Al-Hammadi, M. Sudhadevi, S. Tariq, and A.V. Biradar In vitro study and biocompatibility of calcined mesoporous silica microparticles in mouse lung Toxicol Sci 122 2011 86 99
26. J.H. Park, L. Gu, G. von Maltzahn, E. Ruoslahti, S.N. Bhatia, and M.J. Sailor Biodegradable luminescent porous silicon nanoparticles for in vivo applications Nat Mater 8 2009 331 336
27. S.T. Stern, and S.E. McNeil Nanotechnology safety concerns revisited Toxicol Sci 101 2008 4 21 (Pubitemid 350239008)
28. D. Pozo Immune-based disorders: the challenges for translational immunology J Cell Mol Med 12 2008 1085 1086
29. S.E. McNeil Nanotechnology for the biologist J Leukoc Biol 78 2005 585 594 (Pubitemid 41292080)
30. S.B. Goodman Wear particles, periprosthetic osteolysis and the immune system Biomaterials 28 2007 5044 5048 (Pubitemid 47488481)
31. R.J. Schutte, L. Xie, B. Klitzman, and W.M. Reichert In vivo cytokine-associated responses to biomaterials Biomaterials 30 2009 160 168
32. B.S. Zolnik, A. Gonzalez-Fernandez, N. Sadrieh, and M.A. Dobrovolskaia Nanoparticles and the immune system Endocrinology 151 2010 458 465
33. R. Fernandez-Montesinos, P.M. Castillo, R. Klippstein, E. Gonzalez-Rey, J.A. Mejias, and A.P. Zaderenko Chemical synthesis and characterization of silver-protected vasoactive intestinal peptide nanoparticles Nanomed 4 2009 919 930
34. R. Klippstein, and D. Pozo Engineered nanoparticles for improved vasoactive intestinal peptide (VIP) biomedical applications Recent Pat Nanomed 1 2011 55 59
35. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801 (Pubitemid 43261452)
36. T. Kawai, and S. Akira TLR signaling Semin Immunol 19 2007 24 32 (Pubitemid 46498752)
37. G. Trinchieri, and A. Sher Cooperation of toll-like receptor signals in innate immune defence Nat Rev Immunol 7 2007 179 190
38. F. Romagne Current and future drugs targeting one class of innate immunity receptors: the toll-like receptors Drug Discov Today 12 2007 80 87 (Pubitemid 46014484)
39. I. Nadra, A.R. Boccaccini, P. Philippidis, L.C. Whelan, G.M. McCarthy, and D.O. Haskard Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages Atherosclerosis 196 2008 98 105
40. M. Lucarelli, A.M. Gatti, G. Savarino, P. Quattroni, L. Martinelli, and E. Monari Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles Eur Cytokine Network 15 2004 339 346 (Pubitemid 40127659)
41. K. Flodstrom, and V. Alfredsson Influence of the block length of triblock copolymers on the formation of mesoporous silica Microporous Mesoporous Mater 59 2003 167 176 (Pubitemid 36615270)
42. F. Rouquerol, J. Rouquerol, and K. Sing Adsorption By Powders and Porous Solids: Principles, Methodology and Applications 1999 Academic Press London
43. E.P. Barrett, L.G. Joyner, and P.P. Halenda The determination of pore volume and area distributions in porous substances. 1. Computations from nitrogen isotherms J Am Chem Soc 73 1951 373 380
44. A. Nieto, F. Balas, M. Colilla, M. Manzano, and M. Vallet-Regi Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage Microporous Mesoporous Mater 116 2008 4 13
45. I.I. Slowing, C.W. Wu, J.L. Vivero-Escoto, and V.S.Y. Lin Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells Small 5 2009 57 62
46. P.M. Castillo, J.L. Herrera, R. Fernández-Montesinos, C. Caro, A.P. Zadarenko, and J.A. Mejias Tiopronin monolayer-protected silver nanoparticles modulates interleukin-6 secretion mediated by toll-like receptor ligands Nanomedicine 3 2008 627 635
47. D.F. Fiorentino, A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra IL-10 inhibits cytokine production by activated macrophages J Immunol 147 1991 3815 3822
48. G. Trinchieri Interleukin-10 production by effector T cells: Th1 cells show self control J Exp Med 204 2007 239 243 (Pubitemid 46294539)
49. W. Ouyang, S. Rutz, N.K. Crellin, P.A. Valdez, and S.G. Hymowitz Regulation and functions of the IL-10 family of cytokines in inflammation and disease Annu Rev Immunol 29 2011 71 109
50. M. Vallet-Regi, F. Balas, M. Colilla, and M. Manzano Bone-regenerative bioceramic implants with drug and protein controlled delivery capability Prog Solid State Chem 36 2008 163 191
51. A.V. Kabanov, P. Lemieux, S. Vinogradov, and V. Alakhov Pluronic((R)) block copolymers: novel functional molecules for gene therapy Adv Drug Deliv Rev 54 2002 223 233 (Pubitemid 34230443)
52. J.M. Rosenholm, C. Sahlgren, and M. Linden Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles -opportunities & challenges Nanoscale 2 2010 1870 1883
53. G.A. Kulikova, E.V. Parfenyuk, I.V. Ryabinina, Y.S. Antsiferova, N.Y. Sotnikova, and L.V. Posiseeva In vitro studies of interaction of modified silica nanoparticles with different types of immunocompetent cells J Biomed Mater Res A 95 2010 434 439
54. A. Mantovani, A. Sica, and M. Locati New vistas on macrophage differentiation and activation Eur J Immunol 37 2007 14 16 (Pubitemid 46128780)
55. S. Gordon The macrophage: past, present and future Eur J Immunol 37 2007 S9 S17
56. E. Witasp, N. Kupferschmidt, L. Bengtsson, K. Hultenby, C. Smedman, and S. Paulie Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells Toxicol Appl Pharmacol 239 2009 306 319
57. I.I. Slowing, B.G. Trewyn, and V.S. Lin Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins J Am Chem Soc 129 2007 8845 8849 (Pubitemid 47492073)
58. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat Rev Immunol 5 2005 953 964 (Pubitemid 41746764)
59. M. Motskin, D.M. Wright, K. Muller, N. Kyle, T.G. Gard, and A.E. Porter Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability Biomaterials 30 2009 3307 3317
60. A.J. Di Pasqua, K.K. Sharma, Y.L. Shi, B.B. Toms, W. Ouellette, and J.C. Dabrowiak Cytotoxicity of mesoporous silica nanomaterials J Inorg Biochem 102 2008 1416 1423